Francis Y.K. Yao, M.D.

Professor of Clinical Medicine and Surgery,
Medical Director, Liver Transplant Service
Director for Community Liaison, Liver Transplant Service

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
Fax: 415-476-0659

Clinic
UCSF GI Faculty Practice
350 Parnassus Avenue, Suite 410
San Francisco, CA 94143-0657
Phone: 415-353-2318
Fax: 415-353-2407

Areas of Interest
Hepatocellular carcinoma, cancer staging, clinical trials, adjuvant therapy, outcomes of expanded criteria and down-staging, loco-regional therapy for hepatocellular carcinoma, liver transplantation outcomes, Asian hepatitis and liver cancer treatment and evaluation. Hepatitis B treatment

EDUCATION
1979-1980	University of San Francisco, Chemistry Major
1980-1983	University of California, Berkeley B.S. Chemistry with High Honors
1983-1987	Albert Einstein College of Medicine. M.D. Medicine

TRAINING
1987-1988	Stanford University Hospital, Intern, Internal Medicine
1988-1990	Stanford University Hospital, Resident, Internal Medicine
1990-1993	Stanford University Hospital, Fellow, Gastroenterology

CERTIFICATION
1989-current	Medical Board of California - G 65786
1995	American Board of Internal Medicine - ABIM 147033
1997	American Board of Gastroenterology - ABIM 147033 (Re-certification 2008)

MEMBERSHIPS AND AFFILIATIONS
1996- current	American Liver Foundation, Medical Advisory Committee Northern California Chapter
1998-1999	Department of Transplantation Q.A. Committee, California Pacific Medical Center
2000-current	American Association for the Study of Liver Disease (AASLD) Abstract Review Member
	Research Grants Council of Hong Kong, External Grant Review Member
2007-current	AASLD Education Committee
2007-current	International Liver Cancer Assoc. (ILCA) Founding Member
2007-current	AASLD Abstract Review Member
2008	International Liver Transplant Society (ILTS) - Joint International Congress of ILTS, ELITA, and LICAGE, 2008 Abstract Review Member
2008	The Transplantation Society (TTS), Abstract Review Member

SELECTED PUBLICATIONS

Yao FY, Gautam M, Palese C, Rebres R, Terrault N, Roberts JP, Peters MG. De novo malignancies following liver transplantation: A single center case-control study with long-term follow-up. Clinical Transplantation 2006;20:617-623.
Chao SD, Roberts JP, Farr M, Yao FY*. Short waitlist time does not adversely impact outcome after liver transplantation for hepatocellular carcinoma. American Journal of Transplantation 2007;7:1594-1600.
Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF Expanded Criteria based on Pre-operative Imaging. American Journal of Transplantation 2007; 7:2587-2596.
Yao FY, Kerlan R, Hirose R, Davern T, Bass NM, Feng S, Peters MG, Terrault N, Freise C, Ascher NL, Roberts JP. Excellent long-term outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An Intention-to-treat analysis. Heptology (In press)
Yao FY. Newer antiviral agents and therapeutic approaches for chronic hepatitis B [Invited Review]. Current Hepatitis Reports 2006;5:14-22.
Yao FY. Expanding criteria for hepatocellular carcinoma: Down-staging with a view to Liver Transplantation – Yes [Invited Review]. Seminar in Liver Disease 2006; 26:239-247.
Yao FY. Selection criteria for liver transplantation in patients with hepatocellular carcinoma: Beyond tumor size and number? [Invited Editorial]. Liver Transplantation 2006:12:1189-1191.
Yao FY. Should surveillance for hepatocellular carcinoma be increased in patients with cirrhosis and small liver nodules [Invited Review]? Nature Clinical Practice Gastroenterology and Hepatology 2006;3:544-545.
Yao FY. Liver transplantation for hepatocellular carcinoma: The hepatitis C quandary. [Invited Editorial]. Liver Transplantation 2007;13: 783-785.
Yao FY. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma [Conference Summary]. Hepatology Research 2007;37 (Suppl 2):S267-274.
Hanje AJ, Yao FY. Current approach to down-staging of hepatocellular carcinoma prior to liver transplantation [Invited Review]. Current Opinions in Organ Transplantation 2008;13:234-240.
Yao FY. Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transplant. 2008 Oct;8(10):1982-9.
Mazzaferro V, Chun YS, Poon RT, Schwartz ME, Yao FY, Marsh JW, Bhoori S, Lee SG. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol. 2008 Apr;15(4):1001-7
Hirose R, Yao FY, Stock P, Roberts J, Ascher N. Liver transplantation at UCSF- A 20-year experience. Clinical Transplantation (In Press).
Kashef E, Yao F, Roberts JP. Hepatocellular carcinoma. In: Yeo CJ, Dempsey DT, Klein AS, Pemberton JH, Peters JH (eds). Shackelford's Surgery of the Alimentary tract, 6th ed. Philadelphia: Elsevier, 2006:1732-1742.
Jamshidi R, Yao F. Viral Hepatitis. In: Chin RL (ed). Infectious Diseases in Emergency Medicine. Cambridge University Press, 2008:59-64.
Yao FYK, Feng S, Bass NM. Liver transplantation. In: Yamada T, Alpers DH, Kaplowitz N, Laine L, Owyang C, Powell DW (eds). Yamada's Textbook of Gastroenterology, 5th ed. Philadelphia: Lippincott Williams & Wilkins, (In Press).
Yao FY, Kerlan RK Jr, Hirose R, Davern TJ 3rd, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008 Sep;48(3):819-27.
Yao FY. Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transplant. 2008 Oct;8(10):1982-9
Ladabaum U, Cheng SL, Yao FY, Roberts JP. Cost-effectiveness of screening for recurrent hepatocellular carcinoma after liver transplantation. Clin Transplant. 2011 Mar-Apr;25(2):283-91.
Sapisochin G, Yao FY, Roberts JP. Do preoperative inflammatory markers impact on outcome after liver transplantation for hepatocellular carcinoma? Ann Surg. 2011 Aug;254(2):383; author reply 383-4.
Sapisochin G, Fidelman N, Roberts JP, Yao FY. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl. 2011 Aug;17(8):934-42.